EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical outcomes of injectable and conventional pulmonary valve replacement in severe pulmonary regurgitation

Sercan Tak iD, Murat Koç iD, Ali Kutsal iD, Vehbi Doğan iD

Turkish Journal of Medical Sciences · 16.06.2026 · 56 (3) · 778-786

DOI: 10.55730/1300-0144.6211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 16.06.2026. Verfasst von Sercan Tak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Faculty of Medicine, Gazi University, Ankara, Turkiye. Hauptthemen laut MEDLINE: Pulmonary Valve Insufficiency, Heart Valve Prosthesis Implantation, Pulmonary Valve, Tetralogy of Fallot. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Pulmonary regurgitation following tetralogy of Fallot repair is a common long-term complication requiring pulmonary valve replacement. Injectable bioprosthetic valves offer a less invasive alternative to conventional surgical replacement, but comparative data in pediatric populations remain limited. This study aimed to evaluate short-term and long-term clinical outcomes of injectable pulmonary valve replacement and conventional pulmonary valve replacement in pediatric patients with severe pulmonary regurgitation following tetralogy of Fallot repair. Materials and methods: This retrospective study included 22 pediatric patients who underwent pulmonary valve replacement. Patients were divided into injectable (n = 9) and conventional (n = 13) groups based on anatomical criteria. Primary outcomes included early postoperative parameters and long-term valve function. The mean follow-up duration was 10.5 ± 2.5 years.

Results

Favorable early outcomes were noted in the injectable pulmonary valve replacement cohort, including shorter intensive care unit stay (16.8 ± 6.2 vs. 37.0 ± 23.4 h, p = 0.021), reduced mechanical ventilation duration (5.2 ± 3.9 vs. 15.4 ± 11.4 h, p = 0.019), decreased chest tube drainage (206.7 ± 108.2 vs. 513.1 ± 274.1 mL, p = 0.005), and shorter hospital stay (5.4 ± 2.4 vs. 8.4 ± 3.1 days, p = 0.026). Long-term outcomes indicated similar valve function and right ventricular remodeling in the two groups, with excellent freedom from reintervention (100%) during follow-up.

Conclusion

Injectable pulmonary valve replacement appears to be a safe alternative, offering favorable early outcomes and long-term valve performance comparable to conventional methods. However, clinical experience and precise patient selection remain critical for achieving optimal results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Valve InsufficiencyHeart Valve Prosthesis ImplantationPulmonary ValveTetralogy of FallotHeart Valve ProsthesisBioprosthesisHumansRetrospective StudiesFemaleMaleTreatment OutcomeChildChild, PreschoolInjectionsInfant

Stichwörter der Autor:innen

Tetralogy of Fallotcongenital heart defectsheart surgical procedurepulmonary regurgitationpulmonary valve

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Faculty of Medicine, Gazi University, Ankara, Turkiye.
  • Department of Cardiovascular Surgery, Etlik City Hospital, University of Health Sciences, Ankara, Turkiye.
  • Department of Cardiovascular Surgery, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, University of Health Sciences, Ankara, Turkiye.
  • Division of Pediatric Cardiology, Department of Pediatrics, Etlik City Hospital, University of Health Sciences, Ankara, Turkiye.

ORCID-Profile: Sercan Tak, Murat Koç, Ali Kutsal, Vehbi Doğan

Zitieren

APA

Tak, S., Koç, M., Kutsal, A., & Doğan, V. (2026). Clinical outcomes of injectable and conventional pulmonary valve replacement in severe pulmonary regurgitation. Turkish Journal of Medical Sciences, 56(3), 778-786. https://doi.org/10.55730/1300-0144.6211

Vancouver

Tak S, Koç M, Kutsal A, Doğan V. Clinical outcomes of injectable and conventional pulmonary valve replacement in severe pulmonary regurgitation. Turkish Journal of Medical Sciences. 2026;56(3):778-786. doi:10.55730/1300-0144.6211

BibTeX
@article{Tak2026,
  author = {Tak, Sercan and Koç, Murat and Kutsal, Ali and Doğan, Vehbi},
  title = {Clinical outcomes of injectable and conventional pulmonary valve replacement in severe pulmonary regurgitation},
  journal = {Turkish Journal of Medical Sciences},
  year = {2026},
  volume = {56},
  number = {3},
  pages = {778--786},
  doi = {10.55730/1300-0144.6211}
}
Kostenlos starten →